Results 21 to 30 of about 1,901 (164)
The use of liposomal bupivacaine in fracture surgery: a review
Historically, opioids have played a major role in the treatment of postoperative pain in orthopedic surgery. A multitude of adverse events have been associated with opioid use and alternative approaches to pain relief are being investigated, with ...
Andrew D. Gailey, Robert F. Ostrum
doaj +1 more source
Extended‐release liposomal bupivacaine is frequently used in surgical infiltration for postoperative pain control. The manufacturer recommends against subsequent local anesthetics within 96 hours.
Monica W. Harbell +4 more
doaj +1 more source
Liposomal Bupivacaine in Single-Injection Quadratus Lumborum Block for Pediatric Kidney Transplant: Case Report of a Novel Application. [PDF]
ABSTRACT Background Liposomal bupivacaine is FDA‐approved long‐acting bupivacaine for intraoperative local wound infiltration in pediatric patients 6 years and older, but not for ultrasound‐guided peripheral nerve blocks. There are few prior reports of using liposomal bupivacaine for preoperative peripheral nerve blocks in pediatric patients. We report
Bonaroti R, Ganoza A, Visoiu M.
europepmc +2 more sources
Liposomal Bupivacaine in Transversus Abdominis Plane Block for Postoperative Pain Control After Autologous Breast Reconstruction: A Systematic Review and Meta-Analysis. [PDF]
ABSTRACT Background Autologous breast reconstruction using abdominally based flaps is common post‐mastectomy, but donor‐site pain often leads to prolonged opioid use. The transversus abdominis plane (TAP) block is a common regional anesthesia technique, with bupivacaine as the standard anesthetic.
Almeida VFA +8 more
europepmc +2 more sources
Use of Liposomal Bupivacaine in Pediatric Peripheral Nerve Blocks after Traumatic Amputation
Liposomal bupivacaine has been explored for indications in regional anesthesia, but little has been reported about its use in pediatric patients. In March 2021, the FDA approved an indication for liposomal bupivacaine as an infiltrated local anesthetic ...
Gregory M. Halenda +1 more
doaj +1 more source
Purpose Liposomal bupivacaine demonstrated promise decreasing postoperative pain in total hip and total knee arthroplasty (THA/TKA). Some randomized trials have shown non-superior results; however, confounding variables were not accounted for in such ...
Scott Buzin +7 more
doaj +1 more source
Background: Although single injections with anesthetics are commonly administered given their safety, their short-acting nature limits pain control.
Paul Sang Lee +8 more
doaj +1 more source
Response to “Bupivacaine Liposomal versus Bupivacaine: Comparative Review” [PDF]
To the Editor: The recent article, “Bupivacaine Liposomal Versus Bupivacaine: Comparative Review,” by Noviasky et al [Hosp Pharm. 2014;49(6):539-543] is a valiant effort to review this topic. However, the authors have made a critical oversight in their attempt to interpret analgesic efficacy based solely on pain intensity.
openaire +2 more sources
Advancing design strategies in smart stimulus‐responsive liposomes for drug release and nanomedicine
Schematic illustration of stimulus‐responsive liposomes designed for controlled drug release and nanomedicine. The innermost circle represents different liposomal structures, including unilamellar, multilamellar, and multivesicular liposomes. The middle layer illustrates the responsive phospholipid components.
Yuchen Guo +9 more
wiley +1 more source
Abstract In this report, we describe two cases of diaphragmatic endometriosis with concurrent hepatorenal recess peritoneal involvement managed using robotic‐assisted laparoscopic surgery with the da Vinci Xi platform. In both patients, diaphragmatic implants and hepatorenal recess peritoneal lesions were excised en bloc, followed by resection of ...
Xiaoming Guan +3 more
wiley +1 more source

